Navigation Links
Five AIDS Patients To Receive Experimental Anti-retroviral Drugs

A group of five AIDS victims who have been trying to gain special access to the much sought unapproved anti- HIV drugs (TMC 114 and TMC 125) can now rejoice as the Health Canada // has now issued the medication in what can be considered as a rare clinical trial.

Dr. Montaner, an AIDS drugs specialist with the B.C. Centre for Excellence in HIV/AIDS at St. Paul's Hospital has been trying hard to bring the two unapproved drugs into Canada as a special case. He had even submitted an application to Health Canada in this regard. A special access program that is designed to get unapproved drugs to terminally ill patients was his only hope.

"We started nine months ago looking for treatment. In that time, unfortunately, one [of the six men] has died. We need to make sure we do the best for the patients at all times and not get hung up on unnecessary bureaucratic delays," said Montaner.

Health Canada however refused the request on grounds of inadequate data regarding the synergistic effect of the two drugs. Following this, the doctor and his team sought the help of media and politicians. Unable to withstand the pressure, it has been decided to provide the patients with the drug under a unique approach, a clinical trial.

The chair of St. Paul's ethical-review board that approved the protocol has requested for minor changes to be incorporated in the patient consent forms. The clinical trail is believed to ensure better monitoring of the five patients. A contract would soon by signed between the hospital and the drug supplier, Tibotec Inc., which has agreed to provide the drug free of cost.

The drug is hoped to reach the patients in the coming year. One of the proposed recipient, B.C. artist Tiko Kerr has expressed his feelings of joy following the announcement. He his nervous system has already been affected. Infact he has already lost sensation in his feet and one hand. He manages to do painting with the other hand in which th ere is some sensation preserved.

Health Minister Ujjal Dosanjh has also been very active in ensuring drug supply to the victims. He met another patient, Paul Lewand, chairman of the B.C. Persons with AIDS Society. While the whole world visualises a hopeless end for AIDS victims, this move is expected to infuse an endless hope amongst the five victims.
'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Amphetamines Help Recovery of Stroke Patients
3. Painkillers Do Not Shorten Dying Patients Lives
4. Patients With Filariasis More Prone To HIV Infection
5. Glivec - New Hope For CMC Patients
6. Patients often assume wrongly that they are allergic to penicillin
7. New FDA Approved Drug NATRECOR For Heart Failure Patients
8. Hemochromatosis Patients Blood is Safe
9. Patients Pressure Would Result In Overprescription
10. Risk Of Decongestants In Hypertensive Patients
11. Interference helps Heart Patients
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 25, 2017 , ... Back Pain Centers of America (BPC), which ... physician in their area, announces the launch of a new and proprietary customer relationship ... looking for reputable physicians to help them with back or neck pain and helps ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG CNS Healthcare ... Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national conference. , ... medical devices with a pre-programmed tablet in a remarkably easy-to-use kit for patients. ...
(Date:4/24/2017)... ... 24, 2017 , ... Ridgecrest Herbals makes it a point to lead the ... waste, and support renewable energy. They believe this is a crucial part of their ... for health issues, and maintain that destroying the environment in the pursuit of profit ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has ... and Market Prospects: Addressing Production Complexities Through Risk Management ... ... Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities Through ... assessment of the current trends in the global biosimilars ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology: